Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Immunovative Therapies, Ltd..
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Hadassah Medical Organization
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.
ClinicalTrials.gov Identifier:
NCT00558675
First received: November 13, 2007
Last updated: November 29, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)